Effect of neuromuscular blockade reversal agent on BIS (bispectral index) and PSI (patient state index) under sevoflurane anesthesia in childre
Not Applicable
- Conditions
- Diseases of the musculoskeletal system and connective tissue
- Registration Number
- KCT0006300
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 94
Inclusion Criteria
Pediatric patients who have American society of anesthesiologist physical status ether class I or II
Patients who are planned to undergo elective surgery using sevoflurane anesthesia.
Exclusion Criteria
A person who is in the taboo of using sevoflurane
- Patients with a history of allergy or hypersensitivity reactions, and malignant hyperthermia.
Neuromuscular disease or mental illness
Those diagnosed with metabolic diseases
Long term opioid use
Severe liver, kidney disease
People who have contraindications to muscle relaxants
- Patients who have allergies to drugs or have a history of hypersensitivity reactions, respiratory disease patients, arrhythmia patients
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method comparison of the magnitude of change in Patient State Index and Bispectral Index
- Secondary Outcome Measures
Name Time Method Comparison of the magnitude of change in PSI EMG and BIS EMG;correlation of the change in PSI and BIS ;the pattern of change in BIS ;the pattern of change in PSI;the pattern of change in BIS EMG;the pattern of change in PSI EMG;comparison of the magnitude of change in BIS value between high EMG activity(>=35) and no EMG activity(<35) group